XML 47 R34.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-based Compensation (Tables)
 12 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Share-based Payment Arrangement, Option, Activity
A summary of the status of the Company's stock options at September 30, 2020 and changes during the year then ended is presented below in thousands, except share and per share amounts:
 Options (Shares)Weighted Average
Exercise
Price 		Aggregate
Intrinsic
Value
Outstanding at September 30, 2019770,000 $1.73 $353 
Granted— — — 
Exercised(123,334)1.67 304 
Expired— — — 
Forfeited(546,666)— 606 
Outstanding at September 30, 2020100,000 $1.55 $38 
Exercisable at September 30, 202066,667 $1.68 $16 
The intrinsic value of exercised options for the years ended September 30, 2020 and 2019, in thousands:
20202019
Value at exercise date$510 $— 
Exercise price206 — 
Intrinsic value$304 $— 
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable
Information about the Company’s outstanding and exercisable stock options at September 30, 2020 is as follows, in thousands except share and per share amounts:
Exercise PriceStock Options
Outstanding		Exercisable
Stock Options
Outstanding
Remaining
Contractual
Life  
Aggregate
Intrinsic
Value
$1.28 50,000 16,667 8.25$32 
$1.81 50,000 50,000 6.426 
100,000 66,667 $38 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The estimated fair value at date of grant for stock options utilizing the Black-Scholes option valuation model and the assumptions that were used in the Black-Scholes option valuation model for the fiscal year 2019 stock option grants are as follows:
Estimated fair value of options at grant date$196,970
Black-Scholes model assumptions:
Average expected life (years)6
Average expected volatile factor29%
Average risk-free interest rate2.8%
Average expected dividend yield—
Share-based Payment Arrangement, Expensed and Capitalized, Amount
The Company realized a net benefit related to the recognition of forfeitures of stock options during the year ended September 30, 2020. Compensation expense related to stock options recorded for the years ended September 30, 2020 and 2019 is as follows:
 20202019
Fiscal year 2017 grant $(6)$18 
Fiscal year 2019 grant — 128 
Total compensation expense$(6)$146 
Compensation expense related to restricted stock recorded for the years ended September 30, 2020 and 2019 is as follows, in thousands:
 20202019
Fiscal year 2019 grant15 38 
Fiscal year 2020 grant565 15 
Total compensation expense$580 $53 
Schedule of Non-vested Restricted Share Awards
A summary of the Company's non-vested restricted share awards (RSA) at September 30, 2020 and changes during the year ended September 30, 2020 is presented in the following table:
SharesFair Value
Non-vested at September 30, 201944,118 $60 
Granted764,184 1,569 
Vested (333,278)(571)
Forfeited— — 
Non-vested at September 30, 2020
475,024 $1,058